It is worth mentioning that the combined effects of low-molecular-weight fucoidan (LMWF) and fucoxanthin dramatically enhanced the overexpression of insulin receptor substrate-1 (IRS-1) and glucose transporter type 4 (GLUT4) in a mouse model of type II diabetes (T2D) [206]. The gene discussed is IRS1; the disease is type 2 diabetes mellitus.